GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 262 filers reported holding GLOBUS MED INC in Q2 2019. The put-call ratio across all filers is 4.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $359,000 | +647.9% | 7,519 | +571.3% | 0.10% | +316.7% |
| Q1 2020 | $48,000 | -78.0% | 1,120 | -69.7% | 0.02% | -44.2% |
| Q4 2019 | $218,000 | -11.0% | 3,700 | -22.9% | 0.04% | -32.8% |
| Q3 2019 | $245,000 | +107.6% | 4,800 | +72.1% | 0.06% | +88.2% |
| Q2 2019 | $118,000 | -64.2% | 2,789 | -58.9% | 0.03% | -22.7% |
| Q1 2019 | $330,000 | +164.0% | 6,778 | +133.7% | 0.04% | +10.0% |
| Q4 2018 | $125,000 | -53.7% | 2,900 | -39.6% | 0.04% | -21.6% |
| Q3 2018 | $270,000 | +116.0% | 4,801 | +92.0% | 0.05% | +82.1% |
| Q2 2018 | $125,000 | +40.4% | 2,500 | -16.7% | 0.03% | +40.0% |
| Q3 2017 | $89,000 | -12.7% | 3,000 | -33.3% | 0.02% | +53.8% |
| Q3 2016 | $102,000 | -74.1% | 4,500 | -72.8% | 0.01% | -76.4% |
| Q2 2016 | $394,000 | -69.5% | 16,533 | -69.6% | 0.06% | -63.1% |
| Q1 2016 | $1,290,000 | – | 54,306 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
| Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
| Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
| Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
| Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
| XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
| Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
| Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
| RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |